Mary Kiconco

Assessment of Second-Line Antiretroviral Regimens for HIV Therapy in Africa

Nicholas I. Paton, Cissy Kityo, Anne Hoppé et al. · New England Journal of Medicine · 2014 · 205 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Lopinavir plus nucleoside reverse-transcriptase inhibitors, lopinavir plus raltegravir, or lopinavir monotherapy for second-line treatment of HIV (EARNEST): 144-week follow-up results from a randomised controlled trial

James Hakim, Cissy Kityo, Anne Hoppé et al. · The Lancet Infectious Diseases · 2017 · 41 citations · Full text

Pharmacy, Infectious Disease Control, Pharmacotherapy +17

HIV Drug Resistance Among Children Initiating First-Line Antiretroviral Treatment in Uganda

Cissy Kityo, Kim Sigaloff, T. Sonia Boender et al. · AIDS Research and Human Retroviruses · 2016 · 36 citations · Full text

Public Health, Child Health, Pediatrics +16

Response to Antiretroviral Therapy of HIV Type 1-Infected Children in Urban and Rural Settings of Uganda

Victor Musiime, Joshua Kayiwa, Mary Kiconco et al. · AIDS Research and Human Retroviruses · 2012 · 25 citations

Public Health, Child Health, Pediatrics +14

Second-line HIV Treatment in Ugandan Children: Favorable Outcomes and No Protease Inhibitor Resistance

Ragna S. Boerma, Cissy Kityo, T. Sonia Boender et al. · Journal of Tropical Pediatrics · 2016 · 15 citations · Full text

Pharmacy, Infectious Diseases, Pediatrics +17